Fierce Healthcare March 3, 2022
Kintsugi’s voice biomarker technology works to detect signs of clinical depression and anxiety from short clips of speech in any language.
Startup Kintsugi is using artificial intelligence to build smarter mental health care by helping clinicians detect depression and anxiety in patients more quickly using just their voices.
The company banked $20 million in series A funding to build out its staff, including its marketing, business and operations teams, according to Grace Chang, founder and CEO of Kintsugi.
The funding round was led by New York-based global venture capital and private equity firm Insight Partners. Acrew Capital, Darling Ventures, Citta Capital, Side Door Ventures, Primetime Partners, IT Farm, AngelList Fund and Alpha Edison also participated in the round.
The company...
Today's Sponsors
Today's Sponsors
Today's Sponsor